Alkermes Plc (ALKS)
28.64
+0.28
(+1.01%)
USD |
NASDAQ |
Mar 06, 16:00
28.64
0.00 (0.00%)
After-Hours: 16:47
Alkermes Cash from Investing (TTM) : 295.50M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Avadel Pharmaceuticals Plc | 9.238M |
| Krystal Biotech, Inc. | -58.42M |
| Assertio Holdings, Inc. | -12.57M |
| Amarin Corp. Plc | 8.850M |
| Amicus Therapeutics, Inc. | -46.43M |